UK opens up COVID-19 vaccines to all adults in final push’ for protection Kumar Jeetendra | June 18, 2021 The UK’s health officials on Friday opened up the country’s COVID-19 vaccination programme to all adults, in what has been dubbed as the “final push” to offer protection against the deadly virus. The National Health Service (NHS) said everyone aged 18 and over is being urged to arrange a jab if they have not had …
AstraZeneca vaccine’s investigator backs India’s 12–16-week Covishield dose gap Kumar Jeetendra | June 19, 2021 Backing the 12-16 weeks gap between the two doses of Covishield in India, the chief investigator of the AstraZeneca vaccine clinical trials on June 18 said that the level of protection provided by one dose of the preventive significantly increases in the second and third months after the jab. In an interview with The Wire, …
New programming created to help recognize patients requiring ventilator support: Govt Kumar Jeetendra | June 19, 2021 The government on Saturday said that a new software — Covid Severity Score — has been developed to identify patients who require ventilator support as well as detect emergency and intensive care unit needs early. The software consists of an algorithm that measures a set of parameters, and then identifies patients likely to require ventilator …
Delta variant establishes more than 6% of tested COVID-19 cases with virus variant in NYC: Health division Kumar Jeetendra | June 19, 2021 The Delta variant, first detected in India, constituted over 6 per cent of COVID-19 cases tested for virus variants in New York City, according to official data from the city’s health department. The New York City Health Department said in its recent update that out of the 105 NYC COVID-19 cases tested for variant viruses …
Sputnik V COVID-19 vaccine carry out postponed in Delhi Kumar Jeetendra | June 20, 2021 The roll out of Russian COVID-19 vaccine Sputnik V at Indraprastha Apollo and Madhukar Rainbow Children’s Hospital in Delhi has been delayed for some days, officials said on Sunday. A spokesperson of Apollo Hospitals said the facility in Delhi will tentatively start administering the two-dose vaccine by June 25. An official had earlier said the …
Cadila Pharma launches Posaconazole for treatment of fungal diseases Kumar Jeetendra | June 21, 2021 21 June 2021, Ahmedabad: Pharma major Cadila Pharmaceuticals has launched a new triazole antifungal drug Posaconazole, which has been found to be effective against a wide range of invasive fungal diseases. The drug has also been recommended as a second-line treatment for Mucormycosis or black fungus as it is commonly known. Posaconazole is approved for …
Ladies treated with fertility drugs don’t have expanded breast cancer risk, study shows Kumar Jeetendra | June 21, 2021 Drugs frequently used during fertility treatments to release eggs don’t increase the chance of developing breast cancer, new research has shown. Researchers from King’s College London, in partnership with King’s Fertility, analyzed studies between 1.8 million women undergoing fertility treatments. These women were followed up in studies for a normal period of 27 years and …
China says one billion COVID-19 vaccine dosages administered Kumar Jeetendra | June 21, 2021 China said on June 20 that it has administered over one billion doses of COVID-19 vaccines in the country. China has accelerated its pace of free COVID-19 vaccinations for the whole nation since late March and administered a billion doses by June 19, the National Health Commission (NHC) said. The NHC, however, did not say …
Elisa Antigen Test to Fast-pace India’s testing, monitoring, and Covid-19 management efforts Kumar Jeetendra | June 22, 2021 New Delhi; 22nd June 2021: India’s biotechnology leader in the IVD space, J Mitra and Company has launched the Covid-19 Ag Microlisa Elisa Test kit (Elisa Antigen Test) for the Indian market. The test kit will provide an impetus to India’s fight against Covid-19 by significantly bringing down the overall cost of testing. It will …
AstraZeneca COVID-19 immunization connected to uncommon neurological disorder in India, UK Kumar Jeetendra | June 22, 2021 Eleven people who received the AstraZeneca-Oxford COVID-19 vaccine have developed a rare neurological disorder called Guillain-Barre syndrome, clinicians in India and England have reported in two separate studies. While seven cases were reported from a medical centre in Kerala, where about 1.2 million people were administered the AstraZeneca COVID-19 vaccine, known as Covishield in India, …
IIT-B researcher gets DCGI gesture to launch algo-based COVID-19 testing instrument Kumar Jeetendra | June 22, 2021 Bengaluru-based tech startup Algorithmic Biologics has received regulatory approvals to launch its COVID-19 testing method that can help scale up testing for the deadly virus infection at half the prevailing cost and one-tenth of the time. Called Tapestry, the new testing tool is developed by the startup launched by IIT-Bombay professor Manoj Gopalkrishnan. It enables …
108Labs is building the world’s first cell cultured human milk factory in Hillsborough, NC Kumar Jeetendra | June 22, 2021 Hillsborough, NC – June 21, 2021 – Life Science Newswire – Eighteen months after creating the world’s first cell cultured human milk, 108Labs is now focused on accelerating the field from lab to factory by building and programming the world’s first autonomous Cellufacturing® facility and artificial intelligence platform for production of cell cultured human milk …
